COVID-19 pandemics has evidenced the urgent need of having portable diagnostic tools that enable rapid testing and screening of the population with sensitivity and specificity levels comparable to laboratory techniques. Biosensor technology is one of the best prepared to tackle the challenging goal of offering fast and user-friendly diagnostics tests than can be employed at the point-of-need. We have shown how optical biosensors based on silicon photonics can provide sensitive, reliable and selective analysis, while reducing test and therapeutic turnaround times, decreasing and/or eliminating sample transport, and using low sample volume. And, more importantly, silicon photonics biosensor technology can provide quantification of the viral load, which is of paramount importance in the management of the disease.
|